BioSpace News Archive

Verity Pharmaceuticals Inc. is pleased to announce that as of May 29, 2020, Zeulide Depot™, a hormone therapy for the palliative treatment of prostate cancer, has been added as a General Benefit through the Ontario Drug Benefit Program.

Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, announced that its Board of Directors has declared a quarterly cash dividend payment on the Company’s 10.50% Series E Convertible Preferred Stock.

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a clinically meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, the Company’s Chief Executive Officer, is scheduled to present at the William Blair Growth Stock Conference on Wednesday,

Enzo Biochem, Inc. (NYSE: ENZ) a leading biosciences and diagnostics company, today announced that it will release its third quarter 2020 financial results after the market closes on Monday June 8, 2020.